Back to Search
Start Over
Extracorporeal Treatment for Chloroquine, Hydroxychloroquine, and Quinine Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.
- Source :
-
Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2020 Oct; Vol. 31 (10), pp. 2475-2489. Date of Electronic Publication: 2020 Sep 22. - Publication Year :
- 2020
-
Abstract
- Background: Although chloroquine, hydroxychloroquine, and quinine are used for a range of medical conditions, recent research suggested a potential role in treating COVID-19. The resultant increase in prescribing was accompanied by an increase in adverse events, including severe toxicity and death. The Extracorporeal Treatments in Poisoning (EXTRIP) workgroup sought to determine the effect of and indications for extracorporeal treatments in cases of poisoning with these drugs.<br />Methods: We conducted systematic reviews of the literature, screened studies, extracted data, and summarized findings following published EXTRIP methods.<br />Results: A total of 44 studies (three in vitro studies, two animal studies, 28 patient reports or patient series, and 11 pharmacokinetic studies) met inclusion criteria regarding the effect of extracorporeal treatments. Toxicokinetic or pharmacokinetic analysis was available for 61 patients (13 chloroquine, three hydroxychloroquine, and 45 quinine). Clinical data were available for analysis from 38 patients, including 12 with chloroquine toxicity, one with hydroxychloroquine toxicity, and 25 with quinine toxicity. All three drugs were classified as non-dialyzable (not amenable to clinically significant removal by extracorporeal treatments). The available data do not support using extracorporeal treatments in addition to standard care for patients severely poisoned with either chloroquine or quinine (strong recommendation, very low quality of evidence). Although hydroxychloroquine was assessed as being non-dialyzable, the clinical evidence was not sufficient to support a formal recommendation regarding the use of extracorporeal treatments for this drug.<br />Conclusions: On the basis of our systematic review and analysis, the EXTRIP workgroup recommends against using extracorporeal methods to enhance elimination of these drugs in patients with severe chloroquine or quinine poisoning.<br /> (Copyright © 2020 by the American Society of Nephrology.)
- Subjects :
- COVID-19
Chloroquine therapeutic use
Coronavirus Infections complications
Coronavirus Infections diagnosis
Coronavirus Infections epidemiology
Female
Humans
Hydroxychloroquine therapeutic use
Male
Outcome Assessment, Health Care
Pandemics statistics & numerical data
Pneumonia, Viral diagnosis
Pneumonia, Viral epidemiology
Poisoning therapy
Quinine therapeutic use
Renal Dialysis statistics & numerical data
Risk Assessment
United States
COVID-19 Drug Treatment
Chloroquine poisoning
Coronavirus Infections drug therapy
Hydroxychloroquine poisoning
Pneumonia, Viral drug therapy
Practice Guidelines as Topic
Quinine poisoning
Renal Dialysis methods
Subjects
Details
- Language :
- English
- ISSN :
- 1533-3450
- Volume :
- 31
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Journal of the American Society of Nephrology : JASN
- Publication Type :
- Academic Journal
- Accession number :
- 32963091
- Full Text :
- https://doi.org/10.1681/ASN.2020050564